Barman, Scott A., Shu Zhu, and Richard E. White. Protein kinase C inhibits BKCa channel activity in pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol 286: L149-L155, 2004. First published September 26, 2003 10.1152/ajplung.00207.2003Signaling mechanisms that elevate cyclic AMP (cAMP) activate large-conductance, calcium-and voltage-activated potassium (BKCa) channels in pulmonary vascular smooth muscle and cause pulmonary vasodilatation. BKCa channel modulation is important in the regulation of pulmonary arterial pressure, and inhibition (closing) of the BKCa channel has been implicated in the development of pulmonary vasoconstriction. Protein kinase C (PKC) causes pulmonary vasoconstriction, but little is known about the effect of PKC on BKCa channel activity. Accordingly, studies were done to determine the effect of PKC activation on cAMP-induced BKCa channel activity using patchclamp studies in pulmonary arterial smooth muscle cells (PASMC) of the fawn-hooded rat (FHR), a recognized animal model of pulmonary hypertension. Forskolin (10 M), a stimulator of adenylate cyclase and an activator of cAMP, opened BKCa channels in single FHR PASMC, which were blocked by the PKC activators phorbol 12-myristate 13-acetate (100 nM) and thymeleatoxin (100 nM). The inhibitory response by thymeleatoxin on forskolin-induced BKCa channel activity was blocked by Gö-6983, which selectively blocks the ␣, ␤, ␦, ␥, and PKC isozymes, and Gö-6976, which selectively inhibits PKC-␣, PKC-␤, and PKC-, but not by rottlerin, which selectively inhibits PKC-␦. Collectively, these results indicate that activation of specific PKC isozymes inhibits cAMP-induced activation of the BKCa channel in pulmonary arterial smooth muscle, which suggests a unique signaling pathway to modulate BKCa channels and subsequently cAMP-induced pulmonary vasodilatation.
independent and DAG insensitive (25, 38) . Numerous PKC isozymes are expressed in vascular smooth muscle (␣, ␤, ⑀, , and ␦), which may be dependent on species, type of vessel, and age of the vessel (15, 19, 21, 27) .
Although multiple classes of K ϩ channels are expressed at varying densities in different vascular beds, the large-conductance, calcium-and voltage-activated potassium (BK Ca ) channel is the predominant K ϩ channel species in most arteries (24) . Inhibition of BK Ca channels produces membrane depolarization and subsequent vasoconstriction (30) . The relationship between PKC and BK Ca channel modulation in pulmonary vascular smooth muscle is relatively unknown, although scant evidence suggests PKC inhibition of the BK Ca channel in other types of arterial smooth muscle. Minami et al. (22) observed that PKC blocks activation of the BK Ca channel in coronary artery smooth muscle, Schubert and colleagues (33) reported that PKC reduces BK Ca current in rat tail artery smooth muscle cells, and Barman (5) recently showed that K ϩ channels, including the BK Ca channel, modulate the canine pulmonary vasoconstrictor response to PKC activation.
In light of these previous investigations, the present study was done to determine the effect of PKC activation by phorbol 12-myristate 13-acetate (PMA) and thymeleatoxin on cAMPinduced activation of BK Ca channels by forskolin in pulmonary arterial smooth muscle cells (PASMC) of the fawn-hooded rat (FHR), an animal model of "idiopathic" pulmonary hypertension. PMA, an ester derivative of croton oil, and thymeleatoxin, a phorbol derivative, have been used to study PKCinduced pulmonary vasoconstriction (2, 6, 17) . PMA is an activator of PKC (17) , and thymeleatoxin has recently been shown to cause translocation and downregulation of multiple PKC isozymes (31) . Specifically, the effect of PKC on cAMPinduced BK Ca channel activity was investigated at the cellular and molecular level via the patch-clamp technique in FHR PASMC.
METHODS

Animals.
All procedures and protocols were approved by the Animal Care and Use Committee at the Medical College of Georgia. FHRs were a gift from Dr. I. McMurtry (Cardiovascular Pulmonary Research Laboratory, Dept. of Medicine, Univ. of Colorado Health Sciences Center, Denver, CO), and a breeding colony was established. Animals were maintained on standard rat chow, allowed free access to food and water, and exposed to a 12:12-h light-dark cycle. Male FHRs at 12-16 wk of age were used for this study.
Isolation of PASMC. After the rats were anesthetized with pentobarbital sodium (50 mg/kg ip), a midline incision was made, and the lungs were immediately excised and placed into ice-cold dissociation buffer consisting of (in mM): 110 NaCl, 5 KCl, 0.16 CaCl 2, 2 MgCl2, 10 HEPES, 0.5 NaH2PO4, 10 NaHCO3, 0.5 KH2PO4, 10 glucose, 0.49 EDTA, and 10 taurine. Proximal conduit pulmonary arterial vessels were dissected from the lung lobes under a stereomicroscope. The endothelium was removed, and the adventitia was carefully teased away. The vascular tissue was then dissociated enzymatically at 35°C for 1 h in an incubation solution of dissociation buffer containing the following: 6.7 mg/5 ml papain, 3.5 mg/5 ml cysteine, and 5.0 mg/ml BSA. After incubation, 5 ml of dissociation buffer containing 2 mg/ml of BSA was added to the cell solution, and the tissue was then triturated gently, which allowed individual smooth muscle cells to fall away from the larger pieces of undigested tissue with minimal damage to the cells. These cells exhibited morphology characteristics of vascular smooth muscle cells. The solution was removed and centrifuged at 1,200 rpm for 10 min, and the pellet was then resuspended in dissociation buffer. For patch-clamp experiments, several drops of cell suspension were placed in a microscope chamber containing recording solution, and all experiments were performed within 1-2 h after cell dissociation.
Single-channel experiments. Single potassium channels were measured in cell-attached patches by filling the patch pipette (2-5 M⍀) with normal Ringer solution and making a gigaohm seal on an intact cell. The solution in the recording chamber contained 140 mM KCl, 10 mM MgCl 2, 0.1 mM CaCl2, 10 mM HEPES, and 30 mM glucose (pH 7.4). This manipulation allowed precise regulation of the patch membrane voltage by the patch-clamp amplifier and yielded more accurate current measurements. In experiments measuring potassium channel activity in cell-free inside-out patches, the solution facing the cytoplasmic surface of the membrane had the following composition: 115 mM KCH 3SO3, 26 mM KCl, 2 mM MgCl2, 1 mM BAPTA, 0.47 mM CaCl2 (pCa 7), 5.0 mM Mg-ATP, 0.1 mM GTP, and 20 mM HEPES (pH 7.4). The solution facing the external surface was the standard recording solution. Voltage-clamp and voltage pulse generation was controlled with an Axopatch 200A patch-clamp amplifier (Axon Instruments), and data were analyzed with pCLAMP 6.0.3 (Axon Instruments), which is a comprehensive software package for acquisition and analysis of both whole cell and single-channel currents. Voltage-activated currents were filtered at 2 kHz and digitized at 10 kHz, and capacitative and leakage currents were subtracted digitally. All drugs were diluted into fresh bath solution (1 ml) and perfused into a 2-ml recording chamber (Warner Instruments). Channel activity was quantified by calculating the single channel open probability (NP o) over the duration of the entire data file, as described previously (10, 12, 39, 40) .
Right ventricular hypertrophy measurements. At the time of death, hearts from adult FHR and control male Sprague-Dawley rats (SDR) were removed and dissected to isolate the free wall of the right ventricle from the left ventricle and septum. The ratio of right ventricle weight to left ventricle plus septum weight (RV/LVϩS) was used as an index of right ventricular hypertrophy (13) .
Drugs. Thymeleatoxin, Gö-6976, Gö-6983, and rottlerin were purchased from Calbiochem. All other agents were purchased from Sigma Chemical.
Statistical analysis. All data were expressed as means Ϯ SE. Statistical significance between two groups was evaluated by the Student's t-test for paired data. Comparison among multiple groups was made by using one-way ANOVA for multiple comparisons. A P value Ͻ 0.05 was considered to indicate a significant difference.
RESULTS
Identification of right ventricular hypertrophy.
The RV/ LVϩS in FHR (0.46 Ϯ 0.06; n ϭ 9) vs. control SDR (0.29 Ϯ 0.04, P Ͻ 0.05; n ϭ 9) was indicative of right ventricular hypertrophy in FHR as reported in other studies (20, 23, 32, 37) .
Identification of BK Ca channels in PASMC from FHR. Recordings from cell-attached patches on vascular smooth muscle cells isolated from FHR pulmonary arteries demonstrated that forskolin, an activator of adenylyl cyclase, stimulated the activity of a large-conductance channel that carries outward current (Figs. 1 and 2). As shown in Fig ] to 0.1 mM at the cytoplasmic face of the patch membrane increased channel gating dramatically, indicating the BK Ca channel viability of these cells. Furthermore, previous studies show that this channel has a microscopic conductance of 142 Ϯ 5 pS in symmetric [K ϩ ] (7), which agrees with other studies reporting BK Ca channel conductance in vascular smooth muscle (10, 12) . Collectively, given this specific pharmacological and biophysical profile, we have identified this ion channel as the BK Ca channel, which is highly expressed in vascular smooth muscle.
PKC activators inhibit cAMP-dependent stimulation of BK Ca channels. Intracellular levels of cAMP were increased in PASMC with forskolin (stimulator of adenylyl cyclase), which opened BK Ca channels as previously shown ( Figs. 1 and 2 ). The ability of forskolin to open BK Ca channels was inhibited by compounds that stimulate the activity of PKC. As illustrated in Fig. 3, A and B, application of PMA (100 nM) in the presence of forskolin almost completely (98%) reversed the forskolin-stimulated activity of BK Ca channels in cell-attached patches (NP o : forskolin, 0.0903 Ϯ 0.0198; forskolin ϩ PMA, 0.0014 Ϯ 0.0014; n ϭ 3; P Ͻ 0.001). In addition, 100 nM thymeleatoxin (which activates the ␣, ␤, ␥, ␦, and ⑀ isozymes of PKC) also abolished forskolin-induced BK Ca channel activity (NP o : forskolin, 0.0216 Ϯ 0.0051; forskolin ϩ thymeleatoxin, 0.0007 Ϯ 0.0005; n ϭ 4; P Ͻ 0.001; Fig. 4, A and B) . As shown in Fig. 5 , pretreating cells with either thymeleatoxin or PMA (data not shown) prevented forskolin from opening BK Ca channels. In contrast, thymeleatoxin (100 nM) was unable to inhibit calcium-stimulated BK Ca channel activity in inside-out patches (Fig. 5C ), thus excluding a potential direct inhibitor effect of this toxin on BK Ca channel proteins. Also, incision of the patch into an inside-out configuration and raising cytoplasmic [Ca 2ϩ ] to produce an immediate increase in BK Ca channel activity in the presence of thymeleatoxin indicated the continued BK Ca channel viability in these cells (Fig. 5C) .
Inhibition of specific PKC isozymes reverses the effect of thymeleatoxin. To identify and establish a role for specific PKC isozyme inhibition of forskolin-stimulated gating of BK Ca channels, we used 1 M Gö-6983, a specific PKC isozyme inhibitor, that at this concentration inhibits the ␣, ␤, ␥, ␦, and isozymes of PKC. When PKC activity was inhibited with Gö-6983, thymeleatoxin was unable to prevent the activation of BK Ca channels by forskolin. Specifically, as illustrated in Fig. 6A , pretreating cells with 1 M Gö-6983 for 15 min in combination with 100 nM thymeleatoxin had no effect on BK Ca channel activity (NP o 0.0005 Ϯ 0.0003; n ϭ 4). However, subsequent addition of 10 M forskolin in the presence of both Gö-6983 and thymeleatoxin stimulated channel activity by nearly 50-fold, as shown in Fig. 6 , B and C (NP o 0.0232 Ϯ 0.0057; n ϭ 4; P Ͻ 0.001). These data indicate that Gö-6983 reverses the inhibition of BK Ca channel activity produced by thymeleatoxin. Fig. 2 . Forskolin activation of BKCa channels is blocked by tetraethylammonium (TEA). A: control electrophysiological tracing. B: electrophysiological tracing showing the effect of 10 M forskolin on BKCa channel activity (n ϭ 15). C: electrophysiological tracing showing the effect of TEA ions on forskolin-induced BKCa channel activity. When patches were excised into the inside-out configuration, BKCa channel activity was inhibited by 1 mM TEA (n ϭ 5), a specific blocker of BKCa channels at this concentration. Channel openings are upward deflections from baseline (closed) state.
Fig. 3. PKC activators inhibit cAMP-dependent stimulation of BKCa channels.
A: intracellular levels of cAMP were increased in pulmonary arterial smooth muscle cells (PASMC) with treatment by forskolin for 15 min (stimulator of adenylyl cyclase), which opens BKCa channels (n ϭ 15). A and B: phorbol 12-myristate 13-acetate (PMA; 100 nM, 10 min) in the presence of forskolin almost completely reverses forskolin-stimulated activity of BKCa channels in cell-attached patches (n ϭ 3). Channel openings are upward deflections from baseline (closed) state. Subsequent experiments to gain further insight into the nature of the PKC isozyme(s) that inhibits the effect of forskolin on BK Ca channel activity were done using 1 M Gö-6976 and 1 M rottlerin. At these concentrations, Gö-6976 has a higher degree of selectivity compared with Gö-6983, as it preferentially inhibits the ␣, ␤, and isozymes of PKC, and rottlerin, at this concentration, is a specific inhibitor of PKC-␦. As observed with Gö-6983, pretreating cells with 1 M Gö-6976 for 15 min in the presence of 100 nM thymeleatoxin negated the inhibitory effect of thymeleatoxin-induced PKC activity (Fig. 7) . Specifically, as shown in Fig. 7A , the combination of Gö-6976 and thymeleatoxin did not affect BK Ca NP o (0.0010 Ϯ 0.0006; n ϭ 4). However, subsequent treatment with forskolin in the continued presence of Gö-6976 and thymeleatoxin significantly enhanced BK Ca channel activity above control levels (NP o : 0.1622 Ϯ 0.0513; n ϭ 4; P ϭ 0.02; Fig. 7 , B and C). In contrast, 1 M rottlerin did not reverse the thymeleatoxin inhibitory effect of forskolin on BK Ca channels (Fig. 8, B and C) , since NP o recorded from cell-attached patches was not significantly different before or after addition of 10 M forskolin (NP o : rottlerin ϩ thymeleatoxin, 0.0007 Ϯ 0.0007; rottlerin ϩ thymeleatoxin ϩ forskolin, 0.0042 Ϯ 0.0025; n ϭ 4).
DISCUSSION
The study of pulmonary hypertension has been problematic because of the lack of relevant animal models. In addition, it is difficult in many experimental models to separate the vascular ] produces an immediate increase in BKCa channel activity in the presence of both thymeleatoxin and forskolin, indicating the continued BKCa channel viability of these cells. Fig. 6 . Inhibition of specific PKC isozymes reverses the effect of thymeleatoxin. A: pretreating cells with 1 M Gö-6983 for 15 min in combination with 100 nM thymeleatoxin (15 min) has no effect on BKCa channel activity (n ϭ 4). B and C: subsequent addition of 10 M forskolin (15 min) in the presence of both Gö-6983 and thymeleatoxin stimulates BKCa channel activity by nearly 50-fold (n ϭ 4). Channel openings are upward deflections from baseline (closed) state. Fig. 7 . Inhibition of specific PKC isozymes reverses the effect of thymeleatoxin. A: pretreating cells with 1 M Gö-6976 for 15 min in combination with 100 nM thymeleatoxin (15 min) has no effect on BKCa channel activity (n ϭ 4). B and C: subsequent addition of 10 M forskolin for 15 min in the presence of both Gö-6976 and thymeleatoxin stimulates BKCa channel activity (n ϭ 4). Fig. 8 . Inhibition of specific PKC isozymes does not reverse the effect of thymeleatoxin. A: pretreating cells with 1 M rottlerin for 15 min in combination with 100 nM thymeleatoxin (15 min) has no effect on BKCa channel activity (n ϭ 4). B and C: subsequent addition of 10 M forskolin for 15 min in the presence of both rottlerin and thymeleatoxin has little effect on BKCa channel activity (n ϭ 4). Channel openings are upward deflections from baseline (closed) state.
changes that may be pathogenic from the changes that occur secondary to the hypertension (3). Recently, the FHR has been found to be an excellent animal model to study pulmonary hypertension (20, 32) . The FHR strain is characterized by platelet abnormalities and systemic hypertension and has been widely used to study genetic risk factors for the development of idiopathic pulmonary hypertension (18, 32) . Studies show that the platelet storage disease is not involved in the pathogenesis of pulmonary hypertension (3, 18) , and the FHR strain develops significant pulmonary hypertension, which is not associated with differences in blood gas tension, polycythemia, or parenchymal lung disease (41) . Unlike other rat strains, the FHR develops severe pulmonary hypertension that is age dependent (18) , a phenomenon accelerated under mild hypoxic conditions (32) . Evidence also suggests that the genetic locus for the hypertensive condition is PH1 on chromosome 1 (35) .
The results of the present study indicate that specific PKC isozyme activation inhibits BK Ca channel activity in PASMC of pulmonary hypertensive FHR (as defined by right ventricular hypertrophy) by the cAMP-dependent vasodilator forskolin, which suggests a unique signaling pathway to modulate BK Ca channels in pulmonary arterial smooth muscle. The relationship between PKC and BK Ca channel modulation in pulmonary arterial smooth muscle is relatively unknown, although evidence suggests PKC inhibition of the BK Ca channel in other types of arterial smooth muscle. Minami et al. (22) observed that PKC blocks activation of the BK Ca channel in coronary artery smooth muscle, and Schubert and colleagues (33) recently reported that PKC reduces BK Ca current in rat tail artery smooth muscle cells. Barman (5) recently showed that K ϩ channels, including the BK Ca channel, modulate the canine pulmonary vasoconstrictor response to PKC activation, and Taguchi et al. (36) observed that PKC modulates BK Ca channels in cultured rat mesenteric artery smooth muscle cells. In addition, Boland and Jackson (9) reported that voltage-gated Kv current blocked by PMA (an activator of PKC) was reversed by PKC inhibition. PKC inhibits the delayed rectifier current K ϩ channels in rabbit vascular smooth muscle cells (1), and inhibition of the voltage-gated Kv current in rat intrapulmonary arterial myocytes by endothelin-1 occurs via activation of the PKC pathway (34) . PKC represents an important component of a signal transduction pathway that regulates vascular smooth muscle contraction. The role of PKC in vascular smooth muscle contraction has been investigated using phorbol esters such as PMA and the phorbol derivative thymeleatoxin (2, 16, 17) . Phorbol esters appear to exert their effect through the activation of the enzyme PKC by substituting for DAG (11) . DAG is thought to be one of the endogenous lipids that activates PKC by increasing the affinity of the enzyme for Ca 2ϩ and phosphatidylserine at normal Ca 2ϩ levels (25) . In the present study, both PMA and thymeleatoxin blocked activation of the BK Ca channel by forskolin. Thymeleatoxin is a diterpene derivative of mezerein that has been reported to selectively activate the ␣, ␤, ␦, ␥, and ⑀ PKC isozymes (31) . The inhibitory response by thymeleatoxin on forskolin was blocked by Gö-6983, which selectively blocks the ␣, ␤, ␦, ␥, and PKC isozymes and Gö-6976, which selectively inhibits PKC-␣, PKC-␤, and PKC-at the concentrations used in this study. It is of interest that the BK Ca channel activation (open probability) response to forskolin appeared to be somewhat greater in cells blocked with Gö-6976 than in cells treated with Gö-6983. The reason for this observation is unknown but may be related to the degree of response of individual PASMC to forskolin, the differential blockade of the PKC isozymes, or secondary nonspecific pharmacological effects of the PKC isozyme inhibitors at these concentrations. In contrast, the BK Ca channel activation response to forskolin was still blocked by thymeleatoxin in the presence of the PKC isozyme inhibitor rottlerin, a compound isolated from Mallotus philippinensis, which selectively inhibits PKC-␦ at the concentration used in this study (14) . Although rottlerin also exhibits selectivity for calmodulin (CaM) kinase III at low concentrations (IC 50 ϭ 5.3 M), the concentration used in this study (1 M) would suggest that CaM kinase III is minimally affected by rottlerin. Collectively, on the basis of the pharmacological selectivity of the PKC isozyme inhibitors, these results indicate that activation of specific PKC isozymes (␣, ␤, and ) may modulate cAMP-induced activation of the BK Ca channel in pulmonary arterial smooth muscle. K ϩ channel activity is the main determinant of membrane potential, and associated K ϩ efflux causes hyperpolarization, which inhibits voltage-gated Ca 2ϩ channels and promotes vascular relaxation. Although multiple classes of K ϩ channels are expressed at varying densities in different vascular beds, the BK Ca channel is the predominant K ϩ channel species in most arteries (24) . BK Ca channels are activated by submicromolar [Ca 2ϩ ] i and blocked by external charybdotoxin, iberiotoxin, and TEA ions (24, 25) . The biophysical profile of the BK Ca channel is that it is a large conducting channel (100-150 pS in physiological K ϩ gradients) that is both calcium and voltage dependent for activation (10, 24, 39) . Because of their large conductance and high density, these channels influence resting membrane potential and provide an important repolarizing negative feedback mechanism. Inhibition of BK Ca channels produces membrane depolarization and subsequent vasoconstriction (28) . It should be noted that as the findings from this study are reported in an animal model of pulmonary hypertension, the nature of BK Ca channel modulation in pulmonary vascular smooth muscle may be specific to the physiological conditions present.
In summary, the results of this study indicate that PKC activation by PMA and thymeleatoxin inhibits cAMP-induced BK Ca channel activity in FHR PASMC, which is reversed by the specific PKC isozyme inhibitors Gö-6983 and Gö-6976 but not by rottlerin. Thus this study reveals that specific PKC isozymes may be involved in BK Ca channel inhibition and suggests an important vasoconstrictor signaling mechanism in pulmonary arterial smooth muscle.
